CLINICAL-EVALUATION OF TUMOR-ASSOCIATED TRYPSIN-INHIBITOR (TATI) - PROCEEDINGS OF A SYMPOSIUM HELD IN BARCELONA ON SEPTEMBER 24, 1989 - PREFACE

被引：0
|
作者：
STENMAN, UH [1 ]
BALLESTA, A [1 ]
TORRE, GC [1 ]
机构：
[1] SALITA AL,I-17027 PIETRA LIGURE,ITALY
来源：
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION | 1991年 / 51卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：3 / 3
页数：1
相关论文
共 33 条
  • [21] SERUM LEVELS OF TUMOR-ASSOCIATED TRYPSIN-INHIBITOR (TATI) IN BENIGN AND MALIGNANT GYNECOLOGICAL DISEASES
    TORRE, GC
    REMBADO, R
    BARBETTI, V
    VIGLIERCIO, GP
    FOGLIA, M
    CALABRESE, A
    CORONGIU, F
    SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 1991, 51 : 15 - 18
  • [22] EFFECT OF INTRACAVITARY RADIOTHERAPY ON TUMOR-ASSOCIATED TRYPSIN-INHIBITOR (TATI) IN PATIENTS WITH CERVICAL AND ENDOMETRIAL CANCER
    LEHTOVIRTA, P
    TURPEINEN, U
    STENMAN, UH
    GYNECOLOGIC ONCOLOGY, 1990, 38 (01) : 110 - 113
  • [23] TUMOR-ASSOCIATED TRYPSIN-INHIBITOR (TATI) IN PATIENTS WITH COLORECTAL-CARCINOMA - A CRITICAL COMPARISON WITH CEA
    CATARINO, M
    CONDE, R
    SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 1991, 51 : 43 - 46
  • [24] TUMOR-ASSOCIATED TRYPSIN-INHIBITOR, TATI, IN PATIENTS WITH PANCREATIC-CANCER, PANCREATITIS AND BENIGN BILIARY DISEASES
    HAGLUND, C
    HUHTALA, ML
    HALILA, H
    NORDLING, S
    ROBERTS, PJ
    SCHEININ, TM
    STENMAN, UH
    BRITISH JOURNAL OF CANCER, 1986, 54 (02) : 297 - 303
  • [25] RADIOIMMUNOASSAY OF TUMOR-ASSOCIATED TRYPSIN-INHIBITOR (TATI) - A NEW TUMOR-MARKER FOR CANCER-DIAGNOSIS AND SENSITIVE MONITORING OF THERAPY
    HEIKURA, S
    MAENTAUSTA, O
    LAITINEN, H
    TUMOR BIOLOGY, 1987, 8 (06) : 310 - 310
  • [26] TUMOR-ASSOCIATED TRYPSIN-INHIBITOR (TATI) IN HUMAN OVARIAN-CYST FLUID - COMPARISON WITH CA-125 AND CEA
    HALILA, H
    HUHTALA, ML
    HAGLUND, C
    NORDLING, S
    STENMAN, UH
    BRITISH JOURNAL OF CANCER, 1987, 56 (02) : 153 - 156
  • [27] TUMOR-ASSOCIATED TRYPSIN-INHIBITOR (TATI) AND CANCER ANTIGEN 125 (CA-125) IN MUCINOUS OVARIAN-TUMORS
    MOGENSEN, O
    MOGENSEN, B
    JAKOBSEN, A
    BRITISH JOURNAL OF CANCER, 1990, 61 (02) : 327 - 329
  • [28] OPTIMIZATION OF A TIME-RESOLVED IMMUNOFLUOROMETRIC ASSAY FOR TUMOR-ASSOCIATED TRYPSIN-INHIBITOR (TATI) USING THE STREPTAVIDIN-BIOTIN SYSTEM
    OSMAN, S
    TURPEINEN, U
    ITKONEN, O
    STENMAN, UH
    JOURNAL OF IMMUNOLOGICAL METHODS, 1993, 161 (01) : 97 - 106
  • [29] TUMOR-ASSOCIATED TRYPSIN-INHIBITOR (TATI) - COMPARISON WITH CA125 AS A PREOPERATIVE PROGNOSTIC INDICATOR IN ADVANCED OVARIAN-CANCER
    VENESMAA, P
    LEHTOVIRTA, P
    STENMAN, UH
    LEMINEN, A
    FORSS, M
    YLIKORKALA, O
    BRITISH JOURNAL OF CANCER, 1994, 70 (06) : 1188 - 1190
  • [30] COMPARISON OF TUMOR-ASSOCIATED TRYPSIN-INHIBITOR (TATI) WITH CA125 AS A MARKER FOR DIAGNOSIS AND MONITORING OF EPITHELIAL OVARIAN-CANCER
    GADDUCCI, A
    FERDEGHINI, M
    RISPOLI, G
    PRONTERA, C
    BIANCHI, R
    FIORETTI, P
    SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 1991, 51 : 19 - 24
1234